Zhejiang Jingxin Pharmaceutical Co., Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was CNY 960.43 million compared to CNY 870.57 million a year ago. Revenue was CNY 960.43 million compared to CNY 870.57 million a year ago.

Net income was CNY 151.2 million compared to CNY 137.26 million a year ago. Basic earnings per share from continuing operations was CNY 0.18 compared to CNY 0.16 a year ago. Diluted earnings per share from continuing operations was CNY 0.18 compared to CNY 0.16 a year ago.